- Home
- ADC vs ICLR Comparison
ADC vs ICLR Comparison
Compare ADC & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADC | ICLR |
|---|---|---|
| Founded | 1971 | 1990 |
| Country | United States | Ireland |
| Employees | 90 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 9.3B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | ADC | ICLR |
|---|---|---|
| Price | $75.83 | $146.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $84.50 | ★ $178.62 |
| AVG Volume (30 Days) | 1.1M | ★ 1.1M |
| Earning Date | 04-21-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.12% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.01 | N/A |
| Revenue Next Year | $9.90 | N/A |
| P/E Ratio | $43.33 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $69.56 | $66.57 |
| 52 Week High | $82.08 | $211.00 |
Technical Indicators
Market Signals| Indicator | ADC | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 54.15 | 63.32 |
| Support Level | $74.56 | $99.11 |
| Resistance Level | $76.53 | $188.03 |
| Average True Range (ATR) | 1.21 | 8.29 |
| MACD | 0.29 | 1.04 |
| Stochastic Oscillator | 83.55 | 77.73 |
Price Performance
Historical ComparisonAbout ADC Agree Realty Corporation
Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.
About ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.